Kane Biotech Inc (KNBIF) Stock Price & News

All values in CAD	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Revenue	28.00K	8.50K	-21.14K	43.22K
Cost of goods sold	73.52K	13.63K	-28.71K	47.12K
Cost of revenue	73.52K	13.63K	-28.71K	47.12K
Research and development expenses	90.23K	159.64K	114.94K	208.80K
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	139.70K	378.67K	522.13K	460.61K
Operating expense	229.93K	538.31K	637.07K	669.40K
Total operating expenses	303.45K	551.93K	608.36K	716.52K
Operating income	-275.46K	-543.43K	-629.50K	-673.30K
Other non operating income	-	-	-	-
EBT including unusual items	-348.54K	-607.34K	-654.86K	-710.60K
EBT excluding unusual items	-369.54K	-607.34K	-633.88K	-731.00K
Income tax expense	-	-	-108.00K	4.22K
Effective tax rate	-	-	16.49%	-0.59%
Other operating expenses	-	-	-	-
Net income	-348.54K	-607.34K	-546.86K	-714.83K
Net profit margin	-1,244.92%	-7,146.08%	2,586.83%	-1,654.00%
Earnings per share	-	-	-	-
Interest and investment income	6.11K	7.95K	1.81K	3.08K
Interest expense	-104.76K	-71.86K	-10.14K	-57.88K
Net interest expenses	-98.65K	-63.91K	-8.33K	-54.80K
Depreciation and amortization charges	-	-	-	-
EBITDA	-229.13K	-445.94K	-614.14K	-654.30K
Gain or loss from assets sale	-	-	-27.01K	1.76K

AI content may include mistakes. Learn more

Finance